Trade Pro-Dex - PDEX CFD

Trading Conditions

• Spread: 0.66
• Long position overnight feeLong position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position-0.026179 %(-US$1.05)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position0.003957 %(US$0.16)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-US$1.05)

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  (US$0.16)

Key Stats

• Prev. Close: 18.37
• Open: 17.81
• 1-Year Change: 11.52%
• Day's Range: 17.81 - 18.53

Pro-Dex Company profile

About Pro-Dex Inc

Pro-Dex, Inc. (Pro-Dex) designs, develops, and manufactures of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The Company’s patented adaptive torque-limiting technology and sealing solutions, which appeal to its customers, primarily through medical device distributors. The Company also manufacture and sell rotary air motors to a range of industries. The Company’s patented adaptive torque-limiting software is used in the CMF market. The Company products includes PDSD 5000 powered surgical driver and Precision Air Powered Motors.

Financial summary

BRIEF: For the six months ended 31 December 2021, Pro-Dex Inc revenues increased 20% to $20.2M. Net income decreased 32% to $2M. Revenues reflect Medical devices segment increase of 25% to $16.4M, NRE & Prototypes segment increase from $130K to $311K. Net income was offset by Unrealized gain (loss) on marketable equ decrease from $1.3M (income) to $300K (expense), General and administrative expenses increase of 38% to $2.3M (expense).

Equity composition

Common Stock, no Par, 10/11, 50M auth., 3,272,350 issd. Insiders control31.06%. IPO 8/86, 600K shs @ $5 by Paulson Investment Co. *NOTE: FY'95-'97 are restated for disc. ops. FY'00 fncls. and FY'01 Q's are restated for disc. ops. 06/10, 1-for-3 reverse split.